Fospropofol disodium for preventing emergence agitation and relevant EEG features : a randomised controlled trial

Background Emergence agitation is a clinically important complication during recovery from general anaesthesia. Preventive intervention before emergence may reduce its incidence and the need for rescue treatment. Fospropofol disodium is a water-soluble prodrug of propofol with a gradual sedative profile. We tested whether fospropofol disodium reduces emergence agitation after video-assisted thoracoscopic surgery and explored the potential electroencephalographic mechanisms. Methods In this prospective, single-centre, double-blind, randomised, placebo-controlled trial, adults aged 18–65 year undergoing elective video-assisted thoracoscopic surgery were allocated 1:1 to receive fospropofol disodium 7.5 mg kg⁻¹ or an equal volume of saline at the end of surgery. The primary outcome was emergence agitation, defined as a Riker Sedation-Agitation Scale score ≥ 5 during emergence. Results All 138 randomised patients were analysed (69 per group). Emergence agitation occurred in 13 patients (18.8%) given fospropofol disodium and 31 patients (44.9%) given saline (risk ratio 0.42, 95% confidence interval 0.25–0.71; P = 0.001). Rescue propofol was given to 13 (18.8%) and 30 (43.5%) patients, respectively (risk ratio 0.43, 95% confidence interval 0.25–0.76; P = 0.002). Extubation time did not differ between groups, but post-anaesthesia care unit stay was longer with fospropofol disodium (median 55 [interquartile range 40–68.5] vs 45 [40–60] min; P = 0.021). No statistically significant between-group differences were detected in respiratory or haemodynamic adverse events. Conclusions A single dose of fospropofol disodium at the end of surgery reduced emergence agitation and rescue propofol use, but modestly prolonged post-anaesthesia care unit stay. Larger trials are required to evaluate safety and determine the optimal dose. Clinical trial registration: Chinese Clinical Trial Registry, ChiCTR2500106185 (registered 18 July 2025).

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-20
DOI
https://doi.org/10.21203/rs.3.rs-11407223/v1
Primary Topic
Anesthesia and Sedative Agents
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Fospropofol disodium for preventing emergence agitation and relevant EEG features : a randomised controlled trial

Panpan Fang, Qiuling Du, Xuesheng Liu, Lili Tang et al.
Research Square
Anesthesia and Sedative Agents
preprint

Fospropofol disodium for preventing emergence agitation and relevant EEG features : a randomised controlled trial

Panpan Fang, Qiuling Du, Xuesheng Liu, Lili Tang, Qiu-Yu Liu, Jin-Tao Wang, Ting-Ting Peng
preprint en

Abstract

Background Emergence agitation is a clinically important complication during recovery from general anaesthesia. Preventive intervention before emergence may reduce its incidence and the need for rescue treatment. Fospropofol disodium is a water-soluble prodrug of propofol with a gradual sedative profile. We tested whether fospropofol disodium reduces emergence agitation after video-assisted thoracoscopic surgery and explored the potential electroencephalographic mechanisms. Methods In this prospective, single-centre, double-blind, randomised, placebo-controlled trial, adults aged 18–65 year undergoing elective video-assisted thoracoscopic surgery were allocated 1:1 to receive fospropofol disodium 7.5 mg kg⁻¹ or an equal volume of saline at the end of surgery. The primary outcome was emergence agitation, defined as a Riker Sedation-Agitation Scale score ≥ 5 during emergence. Results All 138 randomised patients were analysed (69 per group). Emergence agitation occurred in 13 patients (18.8%) given fospropofol disodium and 31 patients (44.9%) given saline (risk ratio 0.42, 95% confidence interval 0.25–0.71; P = 0.001). Rescue propofol was given to 13 (18.8%) and 30 (43.5%) patients, respectively (risk ratio 0.43, 95% confidence interval 0.25–0.76; P = 0.002). Extubation time did not differ between groups, but post-anaesthesia care unit stay was longer with fospropofol disodium (median 55 [interquartile range 40–68.5] vs 45 [40–60] min; P = 0.021). No statistically significant between-group differences were detected in respiratory or haemodynamic adverse events. Conclusions A single dose of fospropofol disodium at the end of surgery reduced emergence agitation and rescue propofol use, but modestly prolonged post-anaesthesia care unit stay. Larger trials are required to evaluate safety and determine the optimal dose. Clinical trial registration: Chinese Clinical Trial Registry, ChiCTR2500106185 (registered 18 July 2025).

Research Square
First Affiliated Hospital of Anhui Medical University (CN)
Anesthesia and Sedative Agents
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon